Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia.
Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2010 Dec; 51(12):2222-9.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Antibodies, Monoclonal
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antibodies, Monoclonal, Humanized
Antineoplastic Agents
Antineoplastic Agents
Bevacizumab
Bevacizumab
Female
Female
Humans
Humans
Indoles
Indoles
Leukemia, Lymphocytic, Chronic, B-Cell
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Male
Middle Aged
Middle Aged
Pyrroles
Pyrroles
Quinazolines
Quinazolines
Treatment Outcome
Treatment Outcome
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor A
authors with profiles
Asish K Ghosh